Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Journal of Dairy Science|October 1, 1984
Glucose kinetics, plasma metabolites, and endocrine responses during experimental ketosis in steersR R Lyle, G deBoer, S E Mills, et al.
Journal of Molecular Biology|April 20, 1988
Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomeraseL S Ripley, J S Dubins, J G deBoer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
MYCN protein expression as a predictor of neuroblastoma prognosisH S Chan, B L Gallie, G DeBoer, et al.
The British Journal of Surgery|August 1, 1985
The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanomaP A Kersey, N A Iscoe, J A Gapski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancerJ P Sculier, R Feld, W K Evans, et al.
The Canadian Journal of Urology|March 9, 2004
Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancerR Choo, V Do, L Sugar, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 1994
Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference?N A Iscoe, C D Naylor, J I Williams, et al.
The EMBO Journal|May 6, 1999
A Bub2p-dependent spindle checkpoint pathway regulates the Dbf2p kinase in budding yeastD Fesquet, P J Fitzpatrick, A L Johnson, et al.
The New England Journal of Medicine|December 5, 1991
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastomaH S Chan, G Haddad, P S Thorner, et al.
Breast Cancer Research and Treatment|July 1, 1997
A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1C A Sawka, K I Pritchard, W Shelley, et al.
Pageof 13